Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study-Reference-Cited by-同舟云学术

Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study

Published:2018-06-30 Issue:2 Volume:37 Page:157-166
ISSN:2211-9140
Container-title:Kidney Research and Clinical Practice
language:en
Short-container-title:Kidney Res Clin Pract.

Author:

Jin Kyubok¹,Ban Tae Hyun²,Jung Ji Yong³,Kim Ae Jin³,Kim Yaerim¹,Lee So-Young⁴,Yang Dong Ho⁴,Choi Bum Soon²,Oh Kook-Hwan⁵,Kim Jieun⁶,Kwon Young Joo⁶,Choi Jong Wook⁷,Kim Gheun-Ho⁷^ORCID

Affiliation:

1. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea

2. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Department of Internal Medicine, Gachon University School of Medicine, Incheon, Korea

4. Department of Internal Medicine, CHA University School of Medicine, Seongnam, Korea

5. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

6. Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea

7. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea

Publisher

The Korean Society of Nephrology

Subject

Urology,Nephrology

Link

http://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-02-09.pdf

Reference17 articles.

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl, S1-S130.

2. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters

3. Bone metabolism and disease in chronic kidney disease

4. Gaps between Global Guidelines and Local Practices in CKD-MBD

5. Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Medication Trends for Chronic Kidney Disease: Mineral and Bone Disorder Treatment Using Electronic Health Record-Based Common Data Model;BioMed Research International;2021-11-22

2. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease;Nutrition, Metabolism and Cardiovascular Diseases;2020-08

3. Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease;International Journal of Molecular Sciences;2020-05-17

4. Why do we need regional chronic kidney disease-mineral bone disorders guidelines?;Kidney Research and Clinical Practice;2018-06-30